Surgical treatment of complicated forms of erysipelas
DOI:
https://doi.org/10.34287/MMT.4(47).2020.4Abstract
Purpose of the study. The goal of the article is to find out the frequency of complicated forms of erysipelas among the general population of the disease and to determine the main directions for their surgical treatment.
Materials and methods. 114 case histories of patients who were hospitalized in the center of purulent-septic surgery of the Non-profit municipal enterprise "City Hospital № 3" in Zaporozhye for the period 2019–2020 were analyzed retrospectively and prospectively.
Results. It was found that most often the focus was localized on the upper and lower extremities. In the complex treatment of patients with surgical forms of erysipelas, the main place belongs to antibiotic therapy (ABT) and early surgical treatment of the area of the pathological process. Determination of the level of procalcitonin in blood serum makes it possible to assess the progression of the inflammatory process and is a sensitive test for the effectiveness of treatment.
Conclusions. The incidence of complicated forms of erysipelas requiring surgery in the general population was 78,9%. Patients with circular erysipelas need the most extensive surgery, when it is necessary to perform an autopsy within the area of inflammation with longitudinal and transverse wavy autopsies throughout the pathological focus. Determination of the level of procalcitonin in blood serum makes it possible to assess the progress of the process and is a sensitive test for the effectiveness of treatment.
References
Полякова АС, Бакрадзе ДМ, Иванов АВ и др. Диагностическая ценность определения уровня прокальцитонина в практике инфекциониста. Вопросы современной педиатрии. 2017; 16: 334–41.
Гопаца ГВ, Ермакова ЛА. Рожа: современное состояние проблемы. Научный альманах. 2016; 1–2: 364–6.
Гостищев ВК, Липатов КВ, Комарова ЕА. Стрептококковая инфекция в хирургии. Хирургия. Журнал им. Н.И. Пирогова. 2015; 12: 14–7.
Витик АА, Шепель НП, Суханова НВ, Пыленко ЛН. Предикторы развития сепсиса и септического шока. Вестник интенсивной терапии. 2017; 3: 63–8.
Черкасов ВЛ, Матковский ВС, Иванов АИ. Рожа. Л.: Медицина; 1986. 200 с.
Falconeet Met al. Acute bacterial skin and skin structure infection sininternal medicine wards: old and new drugs. Internaland Emergency Medicine. 2016; 1 (5): 637–48.
Agarwal R, Schwartz DN. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis. 2011 Aug; 53 (4): 379–87.
BruunТet al. Early response in cellulitis: a prospective study of dynamics and predictors. Clinical Infectious Diseases. 2016; 63 (8): 1034–41.
De Jong JA, A van Oerset al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. The Lancet Infectious Diseases. 2016; 7: 1–9.
Singer M et al. Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 801–10.
MilcentКet al. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. JAMA Pediatr. 2016; 170 (1): 62–9.
